Charles Coleman (KAR) exercises options and sells 59,289 shares
Rhea-AI Filing Summary
Charles S. Coleman, EVP, CLO & Secretary of OPENLANE, Inc. (KAR), reported option exercises and share dispositions dated 08/07/2025. The filing shows option-related acquisitions and market sales tied to those exercises, with specific strike and sale prices disclosed.
The report records exercises at a $13.81 strike producing shares and subsequent sales totaling 59,289 common shares at a weighted average sale price of $27.97 (sales ranged from $27.76 to $28.53). Following these transactions the reporting person holds 53,474.483 shares directly. The filer retains derivative exposure through 39,526 employee stock options (exercise price $13.81; expiration 03/04/2031). Footnotes describe grant date (03/04/2021) and vesting conditions for the options.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine option exercise followed by market sales; insider still maintains a meaningful direct stake and outstanding options.
The filing documents the exercise of employee stock options with a $13.81 strike and near-immediate disposition of the resulting shares, yielding sales of 59,289 shares at a weighted average of $27.97 (range $27.76–$28.53). After the transactions the reporting person holds 53,474.483 shares directly and continues to hold 39,526 options expiring 03/04/2031. This is a material disclosure for equity liquidity and insider turnover, but it is consistent with option-exercise mechanics and does not by itself indicate company-level operational changes.
TL;DR: Transaction pattern is typical of option monetization; vesting and grant terms are disclosed in-footnote.
The form identifies grants dated 03/04/2021 with vesting triggers described in the footnotes (25% increments tied to service and share-price hurdles). The reporting shows an exercise price of $13.81 and post-exercise sales at a weighted average of $27.97. The filing properly discloses the number of securities acquired, disposed of, and the remaining beneficial ownership (53,474.483 shares direct and 39,526 options). From a governance perspective this appears to be an orderly, disclosed monetization of vested compensation rather than an unscheduled, unexplained transfer.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 39,526 | $13.81 | $546K |
| Exercise | Employee Stock Option (right to buy) | 19,763 | $13.81 | $273K |
| Exercise | Common Stock | 39,526 | $13.81 | $546K |
| Sale | Common Stock | 39,526 | $27.97 | $1.11M |
| Exercise | Common Stock | 19,763 | $13.81 | $273K |
| Sale | Common Stock | 19,763 | $27.97 | $553K |
Footnotes (1)
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.76 to $28.53 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These options were granted on March 4, 2021 and become eligible to vest and become exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $18.81, $23.81, $28.81, and $33.81, for twenty consecutive trading days, subject to continued employment through such vesting date. These options were granted on March 4, 2021 and vested and became exercisable in equal installments on each of the first four anniversaries of the grant date, and were subject to continued employment through such vesting date.
